Topic: PET Probe Development and Translation: the driving force is Radiochemistry
Join us for TECHNA Rounds as we welcome Dr. Zibo Li, to be our speaker for the month. Dr. Zibo Li obtained his PhD in chemistry from the University of Virginia in 2006. After a postdoctoral position at the Stanford University from 2006-2008, he joined the Molecular Imaging and Biomarker Research division, Siemens Inc as a senior scientist. In Nov 2008, he was recruited as an Assistant Professor at the USC Radiology Department. Currently he is also serving as the chief of radiochemistry research at USC molecular imaging center. Dr. Li received numerous prestigious awards including the highly competitive Mark Tetalman Memorial Award from Society of Nuclear Medicine (2011), which honors the research accomplishments of a young investigator who is pursuing a career in nuclear medicine. With unique experience on translational research, Dr. Li’s research areas include the development of novel labeling methods, multimodality probes, and nanomaterials for visualization and quantification of various molecular targets related to cancer, diabetes, and cardiovascular disease.
Molecular imaging is a fast growing research area involving the development and evaluation of novel tools, reagents and methods to image specific molecular pathways in vivo; particularly those that are key targets in disease processes. Within this area of research, Positron emission tomography (PET) has emerged as one of the most powerful clinical imaging technique, because it can provide critical in vivo information on the
distribution of radiolabeled biomolecules for non-invasive diagnosis. This presentation will focus on the development of novel radiochemistry (especially 18F and 64Cu) for PET probe construction. The radiopharmaceuticals discussed here could have broad application in cancer, diabetes, and cardiovascular disease.